Researchers are investigating whether the body's built-in response to low oxygen can be harnessed to reduce heart damage ...

Johns Hopkins University engineers have created robots the size of a pencil tip intended to travel through the body to ...

The question of whether to pause the weekly injections before an operation just got a very large piece of real-world data.

Cardiologists are struggling to figure out why a drug that should have prevented heart attacks didn’t work at all.

Boston, July 10, 2026 (GLOBE NEWSWIRE) -- The cardiovascular drug development landscape is undergoing a fundamental transformation as artificial intelligence technologies attract unprecedented ...

Weight-loss drugs known as GLP-1s may help protect against heart failure even at doses too low to produce significant weight ...

The failure of two promising heart drugs will almost certainly throw cold water on development of future medications in this ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...

A drug commonly prescribed after a heart attack doesn’t seem to offer significant benefits for people who recover without lasting damage — and could pose added risks to women. In a new research trial, ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Using two types of cardiovascular drugs together could help to treat ...

GLP-1 medications, widely prescribed for diabetes and weight loss, may also help protect people from serious complications ...